[1] Bouchard P, Chabbert-Buffet N, Fauser B C.Selective progesterone receptor modulators in reproductive medicine: pharmacology, clinical efficacy and safety[J]. Fertility and Sterility, 2011,96(5):1175-1189.[2] Schindler A E, Campagnoli C, Druckmann R, et al. Classification and pharmacology of progestins[J]. Maturitas, 2008,61(1-2):171-180.[3] Kumar P, Magon N. Hormones in pregnancy[J]. Niger Med J, 2012,53(4):179-183.[4] Rayhupathy R, Al Mutawa E, Makhseed M, et al. Modulation of cytokine production by dydrogesterone in lymphocytes from women with recurrent miscarriage[J]. BJOG, 2005,112(11):1-6.[5] Skekeres-Bartho J, Wilczinski J R, Baste P, et al. Role of progesterone and progestin therapy in threatened abortion and preterm labor[J]. Front Biosc, 2008,13:1981-1990.[6] Arck P. et al. Early risk factors for miscarriage: a prospective cohort study in pregnant women[J]. Reproductive Biomed Online, 2008,17(1):101-113.[7] Schindler A E. Endocrinology of pregnancy. Consequences for the diagnosis and treatment of pregnancy disorders[J]. J Steroid Biochem Mol Biol, 2005,97(5):386-388.[8] Wahbi H A, Fayed A A, Esmaell S A, et al. Progestogensn for treatment of threatened miscarriages[J]. Cochrane Database Syst Rev, 2011,16(3):CD005943.[9] Schindler Ae. Progestogens for treatment and prevention of pregnancy disorders[J]. HMBCI, 2010;3(3):453-460. |